cardiac hypertrophy

BS69 Characterisation of in vivo and in vitro models for epigenomic investigations of cardiac hypertrophy
Diego Fernández-Aroca, Stephanie Frost, Georgios Tikkas, Adrian Rodriguez, Andrew Tinker, Diego Villar

Heart Jun 2023, 109 (Suppl 3) A296; DOI: 10.1136/heartjnl-2023-BCS.282
85 Enhanced nuclear RSK1 signalling promotes cardiac hypertrophy in mice in vivo, but compromises compensated hypertrophy induced by phenylephrine
Angela Clerk, Kerry Rostron, Daniel Meijles, Stephen Fuller, Peter Sugden

Heart Jun 2018, 104 (Suppl 6) A72; DOI: 10.1136/heartjnl-2018-BCS.85
228 Braf inhibitors, sb590885 and dabrafenib, enhance erk1/2 signalling in cardiomyocytes and promote cardiac hypertrophy
Daniel Meijles, Michelle Hardyman, Kerry Rostron, Stephen Fuller, Peter Sugden, Angela Clerk

Heart Jun 2017, 103 (Suppl 5) A146-A147; DOI: 10.1136/heartjnl-2017-311726.226
218 Knockout p47phox reduces angiotensin ii-induced cardiac oxidative stress and hypertrophy
Fangfei Liu, Junjie Du, Jian-Mei Li

Heart Jun 2017, 103 (Suppl 5) A142-A143; DOI: 10.1136/heartjnl-2017-311726.216
217 Genetic ablation of microtubule-associated protein 1s (map1s) protects the heart from pathological hypertrophy via regulation of autophagy
Yulia Suciati Kohar, Mohammed Najai, Nicholas Stafford, Min Zi, Sukhpal Prehar, Delvac Oceandy

Heart Jun 2017, 103 (Suppl 5) A142; DOI: 10.1136/heartjnl-2017-311726.215
008 Spontaneous cardiac hypertrophy and identification of novel hypertrophic pathways in a genetic mouse model that emulates human diabetes
S M Gibbons, Z Hegab, M Zi, S Prehar, T Mohammed, D Oceandy, M Goldsworthy, R D Cox, E Cartwright, L Neyses, M A Mamas

Heart Jun 2010, 96 (Suppl 1) A8-A9; DOI: 10.1136/hrt.2010.195941.8

Log in using your username and password

Main menu

Log in using your username and password

You are here

cardiac hypertrophy